|
|
US 7,521,446 B2 |
|
| Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| Ronald J. Albers, San Diego, Calif. (US); Leticia Ayala, San Diego, Calif. (US); Steven S. Clareen, San Diego, Calif. (US); Maria Mercedes Delgado Mederos, San Diego, Calif. (US); Robert Hilgraf, San Diego, Calif. (US); Kevin Hughes, San Antonio, Tex. (US); Adam Kois, San Diego, Calif. (US); Veronique Plantevin-Krenitsky, San Diego, Calif. (US); Meg McCarrick, San Diego, Calif. (US); Lisa Nadolny, San Diego, Calif. (US); Moorthy S. S. Palanki, Encinitas, Calif. (US); Kiran Sahasrabudhe, San Diego, Calif. (US); Yoshitaka Satoh, Poway, Calif. (US); Marianne K. Sloss, San Diego, Calif. (US); Elise Sudbeck, San Diego, Calif. (US); and Jonathan Wright, San Diego, Calif. (US) |
| Assigned to Signal Pharmaceuticals, LLC, San Diego, Calif. (US) |
| Filed on Apr. 26, 2006, as Appl. No. 11/411,413. |
| Application 11/411413 is a continuation in part of application No. 11/332617, filed on Jan. 12, 2006. |
| Claims priority of provisional application 60/709980, filed on Aug. 19, 2005. |
| Claims priority of provisional application 60/643796, filed on Jan. 13, 2005. |
| Prior Publication US 2007/0060598 A1, Mar. 15, 2007 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C07D 473/32 (2006.01); A61K 31/52 (2006.01); A61P 3/10 (2006.01); A61P 11/00 (2006.01); C07D 239/50 (2006.01); C07D 239/48 (2006.01)
|
